Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Assenat

Showing results (1-10 of 153) with videos related to

Pageof 16
Sort By:
La Revue Du Praticien|March 16, 2010
[Primary and secondary liver tumours]Eric Assenat
Annals of Translational Medicine|January 25, 2021
Doxorubicin for the treatment of hepatocellular carcinoma: GAME OVER!Boris Guiu, Eric Assenat
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 24, 2025
Reply to: Oxaliplatin Dosing and Toxicity: A Cautionary Perspective on EfficacyEric Assenat, Pierre Senesse
Bulletin Du Cancer|June 17, 2006
[Irinotecan for the treatment of metastatic colorectal cancer]Eric Assenat, Jacqueline Duffour, Marc Ychou
Journal of Hepatology|February 14, 2015
Reply to: "arginase 1: a potential marker of a common pattern of liver steatosis in HCV and NAFLD children"Eric Assenat, Leila Akkari, Marie Moreau, et al.
Endoscopy|May 24, 2014
A new suturing procedure for closure of a gastrocutaneous fistulaNicolas Flori, Julie Courraud, Eric Assenat, et al.
Evolutionary Applications|February 12, 2013
Preventive evolutionary medicine of cancersMichael E Hochberg, Frédéric Thomas, Eric Assenat, et al.
Clinical Journal of Gastroenterology|April 30, 2020
Multimodal treatment including surgery for esophageal adenocarcinoma with liver oligo-metastases: a pathological complete response but early brain metastasisRegis Souche, Marie Dupuy, Jean-Michel Fabre, et al.
Clinical Chemistry|November 14, 2023
Circulating Tumor DNA Clinical Applications in Hepatocellular Carcinoma: Current Trends and Future PerspectivesThomas Bardol, Georges-Philippe Pageaux, Eric Assenat, et al.
Translational Oncology|January 7, 2026
A serum-derived 3D tumor model platform for personalized prediction and monitoring of chemotherapeutic response in pancreatic ductal adenocarcinomaSara Cherradi, Salomé Roux, Marie Dupuy, et al.
Pageof 16

Showing results (1-10 of 153) with videos related to

Sort By:
Pageof 16
La Revue Du Praticien|March 16, 2010
[Primary and secondary liver tumours]Eric Assenat
Annals of Translational Medicine|January 25, 2021
Doxorubicin for the treatment of hepatocellular carcinoma: GAME OVER!Boris Guiu, Eric Assenat
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 24, 2025
Reply to: Oxaliplatin Dosing and Toxicity: A Cautionary Perspective on EfficacyEric Assenat, Pierre Senesse
Bulletin Du Cancer|June 17, 2006
[Irinotecan for the treatment of metastatic colorectal cancer]Eric Assenat, Jacqueline Duffour, Marc Ychou
Journal of Hepatology|February 14, 2015
Reply to: "arginase 1: a potential marker of a common pattern of liver steatosis in HCV and NAFLD children"Eric Assenat, Leila Akkari, Marie Moreau, et al.
Endoscopy|May 24, 2014
A new suturing procedure for closure of a gastrocutaneous fistulaNicolas Flori, Julie Courraud, Eric Assenat, et al.
Evolutionary Applications|February 12, 2013
Preventive evolutionary medicine of cancersMichael E Hochberg, Frédéric Thomas, Eric Assenat, et al.
Clinical Journal of Gastroenterology|April 30, 2020
Multimodal treatment including surgery for esophageal adenocarcinoma with liver oligo-metastases: a pathological complete response but early brain metastasisRegis Souche, Marie Dupuy, Jean-Michel Fabre, et al.
Clinical Chemistry|November 14, 2023
Circulating Tumor DNA Clinical Applications in Hepatocellular Carcinoma: Current Trends and Future PerspectivesThomas Bardol, Georges-Philippe Pageaux, Eric Assenat, et al.
Translational Oncology|January 7, 2026
A serum-derived 3D tumor model platform for personalized prediction and monitoring of chemotherapeutic response in pancreatic ductal adenocarcinomaSara Cherradi, Salomé Roux, Marie Dupuy, et al.
Pageof 16